儿童扁桃体切除术后出血雾化氨甲环酸方案的实施:一项质量改进项目
该质量改进项目纳入501例18岁以下扁桃体切除术后出血患者,分三个时段比较:干预前组、PDSA第1周期(无标准化方案使用雾化氨甲环酸)和PDSA第2周期(实施标准化雾化氨甲环酸方案)。结果显示需手术止血的比例逐期下降(43.9% vs 29.8% vs 15.2%,P < .0001),住院时间、输血率、再入院率及氨甲环酸相关并发症无变化。结论认为实施雾化氨甲环酸方案可能是儿童扁桃体切除术后出血安全有效的管理选择。
要点
- 标准化雾化氨甲环酸方案使需手术止血比例从43.9%降至15.2%。
- 住院时间、输血率、再入院率及氨甲环酸相关并发症无变化。
- 两轮PDSA周期实现手术止血需求降低65.4%,未增加平衡指标。
核心结论
- 实施雾化氨甲环酸方案可能安全有效地减少儿童扁桃体切除术后出血需手术止血的需求。
研究设计与样本
- 质量改进项目,纳入501例18岁以下扁桃体切除术后出血患者,中位年龄7.2岁。
- 干预前组(n=171)收集于2020年1月1日至2022年6月30日。
- PDSA第1周期(n=205)为2022年7月1日至2023年12月31日,患者接受雾化氨甲环酸但无标准化方案。
- PDSA第2周期(n=125)为2024年1月1日至2025年7月13日,实施标准化雾化氨甲环酸方案。
主要发现
- 需手术止血的比例逐期下降:干预前组43.9%,PDSA第1周期29.8%,PDSA第2周期15.2%(P < .0001)。
- 住院时间、输血率、再入院率及氨甲环酸相关并发症在各期之间无变化。
- 两轮PDSA周期实现手术止血需求降低65.4%,平衡指标未增加。
临床怎么用
- 对儿童扁桃体切除术后出血,可考虑实施标准化雾化氨甲环酸方案以减少手术止血需求。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We hypothesized that initiation of a standardized nebulized TXA protocol for posttonsillectomy hemorrhage (PTH) would reduce the need for surgical control of bleeding without increasing adverse clinical outcomes. METHODS: This quality improvement project included patients under 18 years of age who presented with PTH. Preintervention data were collected between January 1, 2020, and June 30, 2022. Plan-Do-Study-Act (PDSA) cycle 1, between July 1, 2022, and December 31, 2023, included patients who received nebulized TXA without a standardized protocol, based on emerging evidence supporting its use in PTH. PDSA cycle 2, between January 1, 2024, and July 13, 2025, followed the implementation of a standardized TXA protocol. Data included need for surgical control of bleeding, length of stay, transfusions, readmissions, and TXA-related complications. RESULTS: A total of 501 patients were included, with a median age of 7.2 years, distributed across the preintervention group (n = 171), PDSA 1 (n = 205), and PDSA 2 (n = 125). The proportion of patients requiring surgical control of bleeding decreased with each intervention (43.9% vs 29.8% vs 15.2%, P < .0001). There were no changes in the length of stay, transfusion rates, readmissions, or TXA-related complications. DISCUSSION: Across 2 PDSA cycles, we achieved a 65.4% reduction in the need for surgical control of bleeding for PTH without an increase in balancing measures, used as surrogates for unintended consequences of the interventions. IMPLICATIONS FOR PRACTICE: Implementation of a nebulized TXA protocol may be a safe and effective management option for PTH.
引用
- Singerman KW, Nguyen A, Welker B, et al. Implementation of a Nebulized Tranexamic Acid Protocol for Pediatric Post-Tonsillectomy Hemorrhage: A Quality Improvement Initiative. Otolaryngol Head Neck Surg. 2026. PMID: 42466952. doi:10.1002/ohn.70341
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。